Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 11, 1997

View Archived Issues

Company Profile: Epicyte

Company Profile: Point Therapeutics

Proof of principle demonstrated for Titan's drug delivery system

Aronex's Nyotran shown effective against aspergillosis

ICAgen receive SBIR grant for ion channel drug target research

Cell Genesys: Q3 1997 highlights

Roberts: Q3 1997 highlights

New oxazolidinone antibiotics described by Zeneca

Neurogen describes dopamine receptor subtype-specific ligands

PPAR-gamma agonists for endocrine and metabolic disorders

Azolobenzazepines claimed by Zeneca for use in stroke

Fujisawa reports heterocyclic glutamate receptor antagonists

MK-966 assessed in large trial in osteoarthritis of the knee and hip

New C5a antagonist reduces cardiac ischemia-reperfusion injury in micropig model

Atypical antipsychotic developed at Esteve characterized

ImaRx presents new ultrasound contrast agent for detecting thrombosis

PNU-96293: KATP channel blocker and eukalemic diuretic

Selective PDE V inhibition with M-54033 beneficial in pulmonary hypertension

Recordati signs licensing agreements with Zeneca, Zambon and Rotta for lercanidipine

Raxar approved in 12 EU countries

DepoCyt to be reviewed by FDA advisory committee this month

Clinical results reported for Roche Bioscience's nepicastat

Humanized anti-CD4 MAb suppresses synovial inflammation/cytokine levels

Orphan Medical receives approvable letter from FDA for Sucraid

FDA clears new indication for Zocor

Clinical results reported for leflunomide in refractory RA and Wegener's granulomatosis

Calcium sensitizer a valuable treatment option for decompensated HF

Roberts completes phase Ia trial of LY-315535

rhIL-1ra provides long-term improvement in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...